Evaluation of the use of PET/CT in Adenoid Cystic Carcinoma (ADC)

Recruiting

• Conditions: Adenoid Cystic Carcinoma; C04.557.470.200.025

• Registration Number: RBR-84nmnm9
• Lead Sponsor: Eduardo Nóbrega Pereira Lima

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-07-31
• Last Update Posted: 22 August 2023
• Study Completion: 2025-01-01

Recruitment & Eligibility

• Status: Recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Age above 18 years. Histological diagnostic confirmation of Neoplasia Adenoid Cystic Carcinoma (ADC). Ability to understand aspects associated with the proposed clinical study and consent to participate.Patients who have performed at least one onventional imaging (computed tomography, magnetic resonance imaging, ultrasonography, and bone scintigraphy) as part of an initial assessment of the extent of neoplastic disease or as part of a recent assessment of ongoing tumor response to CAdC neoplasia.

Exclusion Criteria

Clinical condition that contraindicates the use of targeted imaging for staging conventional or exposure to radiopharmaceuticals such as: ongoing pregnancy, breastfeeding or any condition that the attending physician considers a risk for participation in the study.

Study & Design

• Study Type: Observational
• Study Design: Not specified